The role of autophagy in bone metabolism and clinical significance

J Wang, Y Zhang, J Cao, Y Wang, N Anwar, Z Zhang… - Autophagy, 2023 - Taylor & Francis
The skeletal system is the basis of the vertebral body composition, which affords stabilization
sites for muscle attachment, protects vital organs, stores mineral ions, supplies places to the …

Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review

N Singh, A Miner, L Hennis, S Mittal - Cancer drug resistance, 2021 - pmc.ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an
exceedingly low median overall survival of only 15 months. Current standard-of-care for …

[HTML][HTML] Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance

EH Maleki, AR Bahrami, MM Matin - Genes & diseases, 2024 - Elsevier
Intra-tumor heterogeneity is now arguably one of the most-studied topics in tumor biology, as
it represents a major obstacle to effective cancer treatment. Since tumor cells are highly …

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

S Hombach-Klonisch, M Mehrpour, S Shojaei… - Pharmacology & …, 2018 - Elsevier
Despite advances in neurosurgical techniques and radio-/chemotherapy, the treatment of
brain tumors remains a challenge. This is particularly true for the most frequent and fatal …

Ratiometric analysis of Acridine Orange staining in the study of acidic organelles and autophagy

MP Thomé, EC Filippi-Chiela, ES Villodre… - Journal of cell …, 2016 - journals.biologists.com
Acridine Orange is a cell-permeable green fluorophore that can be protonated and trapped
in acidic vesicular organelles (AVOs). Its metachromatic shift to red fluorescence is …

Targeting autophagy to sensitive glioma to temozolomide treatment

Y Yan, Z Xu, S Dai, L Qian, L Sun, Z Gong - Journal of experimental & …, 2016 - Springer
Temozolomide (TMZ), an alkylating agent, is widely used for treating primary and recurrent
high-grade gliomas. However, the efficacy of TMZ is often limited by the development of …

Genotoxic therapy and resistance mechanism in gliomas

F Lang, Y Liu, FJ Chou, C Yang - Pharmacology & therapeutics, 2021 - Elsevier
Glioma is one of the most common and lethal brain tumors. Surgical resection followed by
radiotherapy plus chemotherapy is the current standard of care for patients with glioma. The …

DNA damage response and autophagy: a meaningful partnership

AG Eliopoulos, S Havaki, VG Gorgoulis - Frontiers in genetics, 2016 - frontiersin.org
Autophagy and the DNA damage response (DDR) are biological processes essential for
cellular and organismal homeostasis. Herein, we summarize and discuss emerging …

Glioblastoma, hypoxia and autophagy: a survival-prone 'menage-a-trois'

S Jawhari, MH Ratinaud, M Verdier - Cell death & disease, 2016 - nature.com
Glioblastoma multiforme is the most common and the most aggressive primary brain tumor. It
is characterized by a high degree of hypoxia and also by a remarkable resistance to therapy …

EMT regulation by autophagy: a new perspective in glioblastoma biology

B Colella, F Faienza, S Di Bartolomeo - Cancers, 2019 - mdpi.com
Epithelial-to-mesenchymal transition (EMT) and its reverse process MET naturally occur
during development and in tissue repair in vertebrates. EMT is also recognized as the …